Technology evaluation: HspE7 (Stressgen).
作者信息
Maciag Paulo Cesar, Paterson Yvonne
机构信息
University of Pennsylvania, Department of Microbiology, 36th St and Hamilton Walk, Philadelphia, PA 19104-6076, USA.
出版信息
Curr Opin Mol Ther. 2005 Jun;7(3):256-63.
PMID:15977424
Abstract
Stressgen is developing HspE7, a recombinant fusion protein comprising the human papillomavirus (HPV) E7 antigen and the heat shock protein Hsp65 from Mycobacterium bovis, as a potential therapy for conditions associated with HPV infection. This therapy is currently undergoing phase III clinical trials.
摘要
Zotero 插件